A curated and standardized adverse drug event resource to accelerate drug safety research.
Ontology highlight
ABSTRACT: Identification of adverse drug reactions (ADRs) during the post-marketing phase is one of the most important goals of drug safety surveillance. Spontaneous reporting systems (SRS) data, which are the mainstay of traditional drug safety surveillance, are used for hypothesis generation and to validate the newer approaches. The publicly available US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data requires substantial curation before they can be used appropriately, and applying different strategies for data cleaning and normalization can have material impact on analysis results. We provide a curated and standardized version of FAERS removing duplicate case records, applying standardized vocabularies with drug names mapped to RxNorm concepts and outcomes mapped to
SUBMITTER: Banda JM
PROVIDER: S-EPMC4872271 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
ACCESS DATA